Comparison of the Efficacy and Safety of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stents in Patients With ST-Elevation Myocardial Infarction
- 15 November 2009
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 104 (10), 1370-1376
- https://doi.org/10.1016/j.amjcard.2009.06.059
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Drug-Eluting Versus Bare-Metal Stents in the Treatment of Patients With ST-Segment Elevation Myocardial InfarctionJACC: Cardiovascular Interventions, 2008
- Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human StudyThe American Journal of Cardiology, 2007
- Zotarolimus-Eluting Stents in Patients with Native Coronary Artery Disease: Clinical and Angiographic Outcomes in 1,317 PatientsThe American Journal of Cardiology, 2007
- The Significance of Preclinical Evaluation of Sirolimus-, Paclitaxel-, and Zotarolimus-Eluting StentsThe American Journal of Cardiology, 2007
- Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarctionAmerican Heart Journal, 2007
- Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)Journal of the American College of Cardiology, 2007
- Overview of Pharmacology and Clinical Trials Program with the Zotarolimus‐Eluting Endeavor StentJournal of Interventional Cardiology, 2006
- Safety and Long-Term Efficacy of Sirolimus Eluting Stent in ST-elevation Acute Myocardial Infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) RegistryCardiovascular Drugs and Therapy, 2006
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003